The role of leukemia inhibitory factor in autoimmune disorders: insights into recovery and treatment
LIF represents a promising target for treating autoimmune diseases, particularly RA and MS. Further research is required to elucidate its mechanisms of action and develop targeted therapies that can control its beneficial effects while minimizing potential adverse outcomes.
Authors
- Fateme Zare (ORCID: https://orcid.org/0000-0003-0436-9924)
- Zahra Rodgarpoor
- Ahmad Meshkin
- Mohammadamin Ehramianpour
Institutions
- Shahid Sadoughi University of Medical Sciences and Health Services (IR)
- University of Science and Arts of Oklahoma (US)
Publication Details
- Journal
- Reumatismo
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4081/reumatismo.2025.1753
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00